Chatillon, France

Christelle Liard

USPTO Granted Patents = 6 

 

 

Average Co-Inventor Count = 3.8

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2018-2024

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Christelle Liard: Innovator in Cancer Vaccines

Introduction

Christelle Liard is a prominent inventor based in Chatillon, France. She has made significant contributions to the field of biotechnology, particularly in the development of innovative cancer vaccines. With a total of six patents to her name, her work focuses on harnessing the immune system to combat cancer in both humans and animals.

Latest Patents

Among her latest patents is a groundbreaking telomerase encoding DNA vaccine. This invention provides a nucleic acid construct that encodes a human telomerase reverse transcriptase (hTERT) protein, which is devoid of telomerase catalytic activity and a nucleolar localization signal. The construct is designed to trigger an immune response against cells that overexpress telomerase, particularly dysplastic or tumor cells. Another notable patent is for a cancer vaccine for cats. This invention includes a nucleic acid or an immunogenic composition that encodes a cat telomerase deprived of telomerase catalytic activity. It also outlines methods for triggering an immune response in cats and for treating or preventing tumors in these animals.

Career Highlights

Christelle Liard has worked with several esteemed organizations throughout her career. Notably, she has been associated with Invectys, a company focused on developing innovative immunotherapies, and the Centre National De La Recherche Scientifique, a leading research institution in France. Her work in these organizations has significantly advanced the field of cancer research and treatment.

Collaborations

Throughout her career, Christelle has collaborated with notable colleagues, including Pierre Langlade Demoyen and Simon Wain-Hobson. These collaborations have further enriched her research and contributed to her innovative projects.

Conclusion

Christelle Liard stands out as a pioneering inventor in the field of cancer vaccines, with her innovative approaches promising to enhance treatment options for both humans and animals. Her contributions continue to inspire advancements in biotechnology and immunotherapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…